On warfarin
Graves’ Disease and Treatment Effects on Warfarin Anticoagulation
... with warfarin 5 mg daily (with an INR goal range of 2-3) was initiated due to AF with a CHA 2 DS 2 -VASc score of one and a CHADS 2 score of ...start warfarin therapy until her hyperthyroidism was ...
7
Combined effect of CYP2C9 and VKORC1 polymorphisms on warfarin maintenance dose in Omani patients
... of warfarin are subject to variations during the treat- ment despite attempts to stabilize the ...on warfarin therapy, we evaluated the extent of influence of known genetic predictors of warfarin ...
6
A role for pharmacists in community based post discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study
... taking warfarin [16,17, ...with warfarin as a result of the face-to-face interaction, increased convenience for the patient, more appropriate use of warfarin in rural and remote areas, and overcom- ...
11
Dental extraction in patients on warfarin treatment
... undergoing warfarin treatment and were referred to the Department of Oral and Maxillofacial Surgery (OMF) for simple dental extrac- ...on warfarin treatment, and no patients taking other antico- agulants of ...
5
Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China
... using the standard forward and backward method. The scale consisted of 18 items that included measuring a patient’s specific beliefs about the administered medicine (possible scores range from 5 to 25), including ...
8
Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
... with warfarin, including 94 female ...of warfarin was ...the warfarin dose, age of the patient and smoking status, while no correlation was observed with the body mass index, gen- der, comorbidities ...
8
A test of financial incentives to improve warfarin adherence
... on warfarin, [1] 32% to 68% of patient-time is spent out of the target therapeutic range, and poor adher- ence is a strong contributor ...their warfarin doses ...prescribe warfarin in the first place ...
6
Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients
... practical warfarin dosing for Korean patients with stroke. The warfarin dosing algorithm was developed on a homogeneous population and single disease indication for stroke, since war- farin have been ...
6
Current strategies to minimize the bleeding risk of warfarin
... antagonist warfarin has been the mainstay of treatment for various conditions that require anticoagulation, including atrial ...of warfarin in both prevention and treatment of thrombosis has been ...
11
An Adaptive Computer Based System for the Prescription of Warfarin
... While patients currently have a blood-test at a medical facility, and have the results processed at a lab, and thereafter interpreted by a doctor, the time for this could be cut down somewhat with the introduction of the ...
40
<p><em>VKORC1</em> variants as significant predictors of warfarin dose in Emiratis</p>
... of warfarin in sporadic ...on warfarin dose and found that after accounting of genetic and nongenetic covariates, the carriers of a single (D36Y) allele require more than double the dose of warfarin ...
11
Pharmacogenetics in warfarin therapy
... To date, we are the first to report a GWAS in a paediatric population on warfarin treatment. Two genetic variants on chromosomal region 5q31.1, rs13167496 and rs6882472, reached genome-wide significance and were ...
221
The critical interaction between valproate sodium and warfarin: case report and review
... receiving warfarin for various reasons [1] and import- antly, 19% of enzyme-inducing AED users reported concomitant usage of ...on warfarin, caution should be taken and the INR should be closely ...of ...
5
Warfarin sodium 2 propanol solvate
... racemic warfarin (Bravic et ...contain warfarin molecules themselves, but instead consist of covalently cyclized molecules of warfarin, which may be described as ...
15
Quality of warfarin management in primary care
... Usual care data are not designed for research and their use is a limitation of this study. We believe the risk of misclassification is low given our reliance on the pres- ence of multiple INR tests, a prescription for ...
10
Patient self-management of warfarin therapy
... years, warfarin ther- apy that preceded the study for more than 3 months and that would be expected to continue for the duration of the study, previous record of compliance with medica- tion, and competence judged ...
7
The Effects of Warfarin on Bone Metabolism
... Bone is a metabolically active organ which has a permanent renewal in the life cycle. This constant renewal is necessary for maintaining the structural integrity and supplying the metabolic functions of the bone as a ...
5
WARFARIN RESISTANCE MECHANISMS AND MANAGEMENT
... blood coagulation factors 2, 3 . Despite extensive efforts, the components of the VKOR complex have not been identified 4, 5, 6, 7, 8 . The complex has been proposed to be involved in two heritable human diseases: ...
5
Monoclonal anti human factor VII antibodies Detection in plasma of a second protein antigenically and genetically related to factor VII
... plasma. Warfarin treatment of HepG2 cells decreased the quantity of VII secreted by 77%, whereas it only inhibited the secretion of VII* by ...chronic warfarin therapy and an individual given a ...
11
Warfarin-induced calciphylaxis: a case report and review of literature
... receiving warfarin for 2 years and 9 months, dyslipidemia, hypertension, chronic kidney disease stage IV, and peripheral vascular disease status post-amputation of the left toe 5 months ...hemoglobin; ...
5